Member Info for Pingu777

Sam I’ve no negative opinion whatsoever. Your taking steps you see fit but experience is an expensive apprenticeship. If you felt you’d done enough research into HEMO to invest your hard earned why would you sell so quickly at a loss? What changed with the company from investing to deciding to sell?

Clearly you can only have been scared out by the price dip As nothing changed at the company. This suggests you didn’t do enough research before you invested. In my opinion. Maybe here lies your weak spot. More research before investing so you’re comfortable with the short term price fluctuations?

I’ve made the same mistakes before chasing rainbows and running from dips. I try to make them as little as possible now.
Hope this helps.

Seller gone. Taking profit from the off. Sensible. How much had they helped hold price down? We’ll see.

Lucagianno
Absolutely Covid is something their tech was perfectly placed to adapt to. But their core work over the last two years will be revolutionary.

I have thought of this share as a potential life changer Spurs. You have the perfect situation I would love it to deliver for. Congrats and good luck!

The project development map has so many matters needing news releases. To not get to £1 hemo has to screw things up sharply and suddenly in areas against the BOD bullish guidance and evidence of success in its work. For me, that is unlikely. Consequently, I predict they get most of the **** done they’ve mentioned. Which means significant uplift and income generated.

Day to day it’s surely impossible to predict? Now 12 months time... I’ll go £1.

“The collaboration agreement, originally scheduled to complete in late April 2020, is being extended by a short period due to the impact on GlobalCo’s operations of the novel coronavirus, following which Hemogenyx will either license the antibody to GlobalCo or will in-license GlobalCo’s improvements to it on favourable terms.“

CDX neutralising antibody tie up with “GlobalCo”. Due end of April but slight delay. This news is IMMINENT and SIGNIFICANT.

He asked for the rationale for a share price increase.

There are of course risks, I’m no tamper, I deal I facts.

As the company uses the funds its raised to continue its hard work do you think there is another placing on the way or do you think they might have planned to release game changing news over the next couple of months to attract a different type of investor to raise funds?

The last placing will get them to where they need to be to transform the company. In my humble (quite well researched) opinion - haha

Junior biotechs come with a high inherent risk of not reaching commercialisation. The New super mice mitigate this so much in many ways.
And a portfolio of multiple asset and product types really does help diversify concentration risk.
If only one of their projects goes commercial the market cap sores. If one goes commercial then why not most of them? Then you won’t be able to see the share price for dust.

For someone talking about fundamentals I’d probably give reading the RNS a go.

-CDX antibody announcement launch imminent with “GlobalCo” yet to be announced, Covid related short delay from end of April.
- 2 Covid plays - risk rating test human cell prevalence to a bad Covid reaction. Creating a antibody drug to treat. No ones sure how long they’ve been working on it but I reckon longer than we think and it’s further down the line.
-lupus antibody treatment in partnership with Johnson and Johnson well in way
-other big pharmas trialing the mice and laying for it. A commercial income from the mighty mice immediately!
HEMO CAR T antibody work to destroy Leukemia cells and replace chemo and radiotherapy. Proven to work. These cells amazing composition and flexibility are being developed as a ‘rapid response bio defence’ against ANY yet unknown future pathogen/disease. MASSIVE.
-hu phec stem cell therapy is revolutionary with patent approvals in USA And shortly Europe. In talk with many partners to take it further.

Yes, the company hasn’t made a bean yet. But this is year three of the companies development of its tech and assets and the company has multiple projects and assets reaching commercialisation. This year will simply be transformational.

DYOR but I’m holding for the months and years to come.

I agree TDT that things could move on once the company re-focus on Sweden. At the moment though it seems 100% on this gold project. Come on pyramid find our fluorspar asset pushes!!!!!

Confident CDX Is going to be streets in front of the current ALL treatment KYMRIAH from Novartis. It’ll smash the market share if GlobalCo is any good at their job. Hundreds of millions straight up.

A company called FAB has had a go at larger animals but the specificities with the mice is absolute speed and reliability of the human replication. The benefit of mice is that the process is rapid, cheap and can be relocated in larger numbers.

Thanks asat, spot on.

I think there are a few secret partners waiting in the wings for HEMOs mice and CDX and an affective bio-defence rapid response, in general, never mind just Covid.

The speed of the magic mice testing a new pathogen is our USP.

Got a link? Janssen pharma currently working with Hemo on the Lupus project (as well as Covid maybe?) and has the capacity to crank up production surely if required. Interesting.

Drill results to come. It’s exciting! Surely they’ve a decent chance of a commercial find? I remain moderately positive.

I’m gonna go crazy and say it’ll double this week. We will see.

I got a couple of grands worth This aft. Buy not shown up on this site. Been watching this one for a while ... can’t believe it’s still so cheap. Plenty of work to be done but the rewards for a successful power plant in 3yrs time are astronomical.

:-)

You sure?